slides · global inventory
Comparison Table
Framework collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 318
Current window 241-270
Pages 11
Rows per page 30
Framework
241-270 of 318
12
The slide uses a matrix-like structure to compare two strategic options.Antero Midstream Partners | Mergers and Acquisitions Presentation Deck | 34 slides · Antero Resources
Deck Investment bank Beat · Evidence & ProofLoop · Mece Breakdown1 hit
16
The slide uses a matrix structure to compare financial strategies.Antero Midstream Partners | Mergers and Acquisitions Presentation Deck | 34 slides · Antero Resources
Deck Investment bank Beat · Solution & ApproachLoop · Cost Of Inaction1 hit
13
Antero Midstream Partners | Mergers and Acquisitions Presentation Deck | 69 slidesAntero Midstream Partners | Mergers and Acquisitions Presentation Deck | 69 slides · Antero Resources
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Pattern Hunter1 hit
22
The slide uses a dot-based matrix to indicate full vs partial capabilities.Blockbuster Video | Investor Presentation Deck | 74 slides · Blockbuster
Pitch deck Investor relations Beat · SolutionLoop · Mece Breakdown1 hit
59
The slide uses a dot-based matrix to indicate full vs partial capabilities.Blockbuster Video | Investor Presentation Deck | 74 slides · Blockbuster
Pitch deck Investor relations 1 hit
14
The table compares 7 distinct operational metrics between the Bluejay Symphony and competitors (Beckman, Siemens, Roche).Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations 1 hit
07
The slide uses a structured table format to highlight specific shifts in consideration, conditions, and termination payments.Centerview Partners | Investment Banking Pitch Book | 31 slides · Centerview Partners
Consulting deck Investment bank 1 hit
25
Centerview Partners | Investment Banking Pitch Book | 31 slidesCenterview Partners | Investment Banking Pitch Book | 31 slides · Centerview Partners
Consulting deck Investment bank 1 hit
25
The slide uses a detailed comparison table to highlight the competitive positioning of CG Oncology's CORE-001 trial against other industry players.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
43
The slide explicitly notes that these are not head-to-head studies and differences in study design exist.CG Oncology | IPO Presentation Deck | 45 slides · CG Oncology
Pitch deck Investment bank 1 hit
07
The slide uses a table to contrast financial metrics and production strategies, positioning Eos as more efficient than competitors.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
18
The slide uses a custom table structure to show how specific technical advantages (RTE, Auxiliary Power, etc.) contribute to a total IRR delta.Eos Energy | Investor Presentation Deck | 24 slides · Eos Energy Enterprises
Pitch deck Investor relations Beat · SatisfactionLoop · Voice Of Customer1 hit
18
The slide highlights US FDA Fast Track designation and superior PFS performance.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
82
The slide uses a heatmap-style table to visualize performance against criteria, with a specific callout box highlighting the UGT1A1 row.Exscientia | Investor Day Presentation Deck | 90 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
16
The table uses a color-coded heatmap (green/yellow/red/grey) to indicate performance against criteria.Exscientia | Results Presentation Deck | 22 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
23
The table highlights USA's ranking (#1 or #2) across various financial metrics.IAC | Investor Presentation Deck | 47 slides · USA Interactive
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
24
The slide highlights USA Interactive's metrics relative to major internet peers.IAC | Investor Presentation Deck | 47 slides · USA Interactive
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
06
The slide uses a comparison table to benchmark Home Services against established marketplaces like Uber, Airbnb, and Zillow. A hand-drawn orange circle highlights the 3-4% take rate for Home Services.IAC | Mergers and Acquisitions Presentation Deck | 18 slides · IAC
Deck Investment bank Beat · Market Size1 hit
29
The table compares NXC-201 against Darzalex, CAEL-101, and Birtamimab across various clinical metrics.Immix Biopharma | Investor Presentation Deck | 56 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
22
The slide uses a table structure to contrast patient segments and includes a bar chart visualization for patient growth.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
32
The table uses a cross-trial comparison format. The red dashed box highlights the key clinical data rows.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Evidence & ProofLoop · David Goliath1 hit
44
The table compares clinical trial inclusion criteria across four different therapies, focusing on prior lines of therapy, toxicity recovery, ECOG status, and measurable disease definitions.Immix Biopharma | Investor Presentation Deck | 62 slides · ImmixBio
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
34
The table uses a red dashed box to highlight key clinical efficacy and safety metrics (ORR, CR, ICANS, CRS).Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Evidence & Proof1 hit
20
The slide uses a matrix structure to evaluate potential financial buyers for a transaction.J.P.Morgan | Investment Banking Pitch Book | 33 slides · JPMorgan
Consulting deck Investment bank Beat · Solution & Approach1 hit
16
The table highlights DA-1726's dual agonist mechanism and potential for better tolerability compared to market leaders.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · Product1 hit
16
The table highlights DA-1726's dual agonist mechanism (GLP-1R/GCGR) as a key differentiator against standard GLP-1 agonists.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
09
The slide uses a structured table to contrast two distinct patient populations (ALK+ vs ROS1+) across three lines of therapy (1L, 2L, 3L+).Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
14
The slide uses a matrix-like structure to compare drug generations against clinical outcomes.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 1 hit
06
The slide uses a ranking system (1-6) for each metric, highlighting SiriusXM in blue.SiriusXM | Investor Presentation Deck | 26 slides · SiriusXM
Pitch deck Investor relations Beat · NeedLoop · Pattern Hunter1 hit
21
The slide uses a scroll-like visual metaphor to present three distinct columns of data.Toys R Us | Investor Presentation Deck | 28 slides · Toys R Us
Pitch deck Investor relations 1 hit